Jutro Medical, the AI-first primary care operator integrating online and offline care, has raised €24 million led by Warsaw Equity Group, with participation from Vinci, naturalX Health Ventures , Fluent Ventures, Aternus, KAYA VC, and Inovo VC. This new capital extends the company’s previously announced Series A, bringing its total amount to €36 million. The round also includes a debt component from mBank and Orbit Capital.
Founded in 2020, Jutro Medical has grown from a single clinic focused on providing high-quality care and improving the patient journey through technology into a fully integrated primary care operator with its own EHR, scalable clinic operations and AI agents. The company now runs 20 clinics and provides care to 120,000 patients across Poland, maintaining an average rating of 4.94 out of 5 across more than 500,000 visits and an NPS of 86.
AI scale and technical foundation
The company is growing 270 percent year over year. In the past month alone, doctors visits supported by AI reached nearly 1,500, confirming the system’s readiness for scale. This level of AI involvement in day-to-day clinical operations places Jutro among the first healthcare operators in Europe to successfully deploy automation in primary care at this depth and scale.
For the first four years, Jutro Medical focused on building its proprietary electronic health record system, creating the software and data layers that powers every clinic. Now, building an AI-layer on top of this software and data foundation is significantly easier and faster. This groundwork allows Jutro Medical’s AI agents to take over much of the administrative work, letting doctors focus on clinical decisions and giving the company a clear advantage in deploying AI at scale.
The AI agents operate within these validated workflows, taking over intake, and suggesting propositions for visit documentation. Doctors enter the visit with the context already prepared, review the information, ask the patient additional necessary questions and remain responsible for all clinical decisions. The use of AI is fully opt-in, and patients can always choose a traditional appointment.
Europe’s primary care capacity challenge
Primary care continues to face significant workforce pressures. The number of available doctors is not keeping pace with rising patient demand, and clinics struggle to maintain capacity as administrative workloads increase. Access to care varies widely between regions, with many providers operating at or near full utilization. Spending on primary care exceeds €200 billion a year in Europe, including around €9 billion in Poland, yet many clinics still rely on manual, paper-based processes that slow access to care and strain an already limited capacity.
“By running our own clinics on our own software, we’ve learned firsthand which tasks can be handled by AI. Instead of hiring more staff, we now build AI agents that do the same work – freeing clinicians to practice medicine, not paperwork. These agents already manage thousands of patients interactions every month,” says Adam Janczewski, founder and CEO of Jutro Medical.
Expansion and AI rollup strategy
Jutro Medical is the first operator in Europe to apply the AI rollup model to primary care at scale. The company acquires clinics and brings them onto a unified operational and technological platform, giving each location access to the same EHR, workflow system and AI agents. This year alone, Jutro has added nine clinics into its network and is on pace to complete around 20 acquisitions annually. The unified model guarantees consistent quality, accelerates integration and improves margins across the network.
The new capital will support further clinic acquisitions in Poland and enable the company to expand its rollup model by buying and integrating primary care clinics across Europe. Jutro Medical will continue developing new AI agents that take over additional administrative and operational tasks, leaving doctors to focus solely on diagnosis and treatment. With over 100,000 small practices in Europe, Jutro aims to create a pan-European primary care operator setting a new standard for publicly funded care.
“Primary care is undergoing significant structural change across Europe, with thousands of small GP practices approaching retirement each year,” said Jan Szumada, Investment Manager at Warsaw Equity Group. “Jutro Medical is capitalising on this opportunity – nearly quadrupling its revenue year over year while keeping EBITDA around break-even – a rare combination in this market. At WEG, we invest in companies whose technology delivers meaningful customer value and reshapes their industries. We’re excited to back a team that is proving the AI-rollup strategy works and support them as they build a pan-European operator targeting more than €1 billion in revenue.”
“For us, this is a strategically important investment in the healthcare sector, and the key factor behind our decision was Jutro Medical’s mission to improve access to high-quality healthcare in Poland and across Europe,” said Bartosz Drabikowski, CEO of Vinci. “Through the practical use of AI agents in everyday clinical operations, the company enables doctors to spend more time with patients, reduces waiting times and improves access to medical services. The fact that these solutions are already being implemented at scale and deliver clear value for both patients and clinicians was an important consideration in our investment decision, and we are pleased to support Adam and his team in the next stage of growth.